How do left, center, and right outlets frame this story?

Kinoxis pockets $9.25m to push dementia agitation drugs through trials, with results due in 2027.

Where can I read the original reporting?

Kodawire links to 1 source for this story.

Bias Comparison — Dementia biotech Kinoxis raises $6.75 million with a $2.5m grant as cherry on top

Media Spectrum

Total: 1 source•Published: 24m ago•Last Updated: 2m ago

0%100%0%

LeftCenterRight

Left-leaning

Coverage Gap

Unreported by left-leaning outlets. Coverage is currently concentrated on other perspectives.

0 sources

Center

100% of coverage

SD

Startup Daily

Dementia biotech Kinoxis raises $6.75 million with a $2.5m grant as cherry on top

View all 1 sources

Right-leaning

Coverage Gap

Unreported by right-leaning outlets. Coverage is currently concentrated on other perspectives.

0 sources

Bias & Framing Analysis

Top Framing Differences

Left: Coverage gap: Currently unaddressed by verified outlets on this side of the spectrum.
Center: Kinoxis pockets $9.25m to push dementia agitation drugs through trials, with results due in 2027.
Right: Coverage gap: Currently unaddressed by verified outlets on this side of the spectrum.

Overall Tone

Center

Coverage Blindspots

Left

Coverage blindspot: Reporting on this development is currently concentrated in other segments of the media landscape.

Right

Coverage blindspot: Reporting on this development is currently concentrated in other segments of the media landscape.

Credibility & Editorial Standards

Story FramingCenter

Evaluated across 1 reporting source (0% Left · 100% Center · 0% Right)

L 0%C 100%R 0%

Outlet ConsensusCenter

Historical editorial baseline for Startup Daily

TechCenter

Politics & GovernanceCenter

Credibility ScoreHigh Credibility

89/ 100

Multi-factor accuracy index for Startup Daily and related desks based on verifiable sourcing and editorial standards.

Factuality: High 100%

Ownership: Startup Daily (Corporate)

Timeline of this story

21m agoStartup Daily: Kinoxis pockets $9.25m to push dementia agitation drugs through trials, with results due in 2027.

Historical Context

2024 — EU Artificial Intelligence Act

World’s first binding horizontal regulation on risk-tiered AI models enters into force.

2023 — Generative AI Deployment Boom

Large language models trigger global compute buildout and frontier safety accords.

2022 — Global Semiconductor Legislation

U.S. and European Chips Acts direct hundreds of billions into domestic fabrication fabs.

Posts on X

Public conversation related to this story

From project management and customer service to human resources (HR) and finance, businesses have access to more prebuilt software options than ever before. However, buying prebuilt software that is designed to serve businesses across a range of industries is unlikely to accommodate your specific needs. That’s why many businesses are building custom tools, rather than […] The post Build vs buy: Why custom tools are winning in 2026 appeared first on e27 .

L 0%C 100%R 0%

4 sources • 4

Brandon Nimmo’s focus is on Rangers’ playoff hopes — not his Mets past

Multiple outlets • 13m ago

Brandon Nimmo is enjoying this new chapter of his career with a chance for a postseason return.

L 0%C 0%R 100%

2 sources • 2

Umpire felt threatened by Hawks players’ abuse, reveals phone call with Barrass

Multiple outlets • 15m ago

Umpire Hayden Meyer said he was taken aback when two Hawthorn players abused him post game as he was announced as one of the four grand final field umpires for Saturday.

L 67%C 33%R 0%

3 sources • 3

‘Repeating a lie doesn’t make it true’: Israel releases exposé of UN’s bias before General Assembly

Multiple outlets • 1m ago

The Ministry of Diaspora Affairs and Combating Antisemitism and the National Public Diplomacy Directorate in the Prime Minister's Office launched the campaign in an attempt to reveal the UN's lies.

L 0%C 100%R 0%

1 sources • 1

Winter criticizes Katz's Gaza statements, calls for action over empty threats

Multiple outlets • 1m ago

"Stop making threats if you don't intend to follow through...it certainly isn't security, and it certainly isn't victory," Winter said.

L 0%C 100%R 0%

1 sources • 1

Full house as Eagles begin training for Madagascar clash

Multiple outlets • 5m ago

23 Super Eagles players have begun training in Uyo for their 2027 Africa Cup of Nations qualifying opener against Madagascar on Friday.

L 0%C 100%R 0%

1 sources • 1

Reader Discussion

Loading comments…

Dementia biotech Kinoxis raises $6.75 million with a $2.5m grant as cherry on top